Literature DB >> 12063482

Erythropoietic protoporphyria: altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations.

Maureen B Poh-Fitzpatrick1, Xiuhua Wang, Karl E Anderson, Joseph R Bloomer, Brian Bolwell, Alan Eli Lichtin.   

Abstract

Acute myelogenous leukemia occurred in a 47-year-old woman whose 25-year history of cutaneous photosensitivity had been undiagnosed until abnormally high erythrocyte, plasma, and fecal protoporphyrin levels were discovered during evaluation for her hematologic disorder. She was found to be heteroallelic for ferrochelatase gene mutations, bearing a novel missense mutation caused by a C185-->G (Pro62-->Arg) transversion in exon 2 of one allele, and a previously described g-->a transition at the +5 position of the exon 1 donor site of the other allele, confirming a diagnosis of erythropoietic protoporphyria. Successful bone marrow transplantation from her brother, who is a mildly affected bearer of the second mutation, resulted in remission of the leukemia and in conversion of the protoporphyria phenotype of the recipient to one resembling that of the donor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12063482     DOI: 10.1067/mjd.2002.120460

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  The diagnosis and management of erythropoietic protoporphyria.

Authors:  Manish Thapar; Herbert L Bonkovsky
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

2.  In vivo binding of protoporphyrin IX to rat translocator protein imaged with positron emission tomography.

Authors:  Harushige Ozaki; Sami S Zoghbi; Jinsoo Hong; Ajay Verma; Victor W Pike; Robert B Innis; Masahiro Fujita
Journal:  Synapse       Date:  2010-08       Impact factor: 2.562

Review 3.  Liver disease in erythropoietic protoporphyria: insights and implications for management.

Authors:  A V Anstey; R J Hift
Journal:  Postgrad Med J       Date:  2007-12       Impact factor: 2.401

Review 4.  Liver disease in erythropoietic protoporphyria: insights and implications for management.

Authors:  A V Anstey; R J Hift
Journal:  Gut       Date:  2007-03-14       Impact factor: 23.059

5.  Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria.

Authors:  Laurent Gouya; Caroline Martin-Schmitt; Anne-Marie Robreau; Frederic Austerlitz; Vasco Da Silva; Patrick Brun; Sylvie Simonin; Said Lyoumi; Bernard Grandchamp; Carole Beaumont; Herve Puy; Jean-Charles Deybach
Journal:  Am J Hum Genet       Date:  2005-11-15       Impact factor: 11.025

6.  Liver transplantation for acute-on-chronic liver failure from erythropoietic protoporphyria.

Authors:  Pyoung-Jae Park; Shin Hwang; Young-Il Choi; Young-Dong Yu; Gil-Chun Park; Sung-Won Jung; Sam-Youl Yoon; Gi-Won Song; Tae-Yong Ha; Sung-Gyu Lee
Journal:  Clin Mol Hepatol       Date:  2012-12-21

Review 7.  Protoporphyrin IX: the Good, the Bad, and the Ugly.

Authors:  Madhav Sachar; Karl E Anderson; Xiaochao Ma
Journal:  J Pharmacol Exp Ther       Date:  2015-11-20       Impact factor: 4.030

8.  From the dermatologikum hamburg: quiz.

Authors:  Wendemagegn E Yeshanehe; Rajalakshmi Tirumalae; Almut Böer-Auer
Journal:  Dermatol Pract Concept       Date:  2012-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.